Business drivers: The US biotech company Halozyme Therapeutics (HALO) specializes in products related to proprietary enzyme technology. The ENHANZE technology developed by Halozyme allows for the subcutaneous administration of biological and medicinal substances, which offers significant advantages compared to traditional intramuscular or intravenous...
The Best Growth Stocks by Revenue & Profit
Stocks with high revenue and earnings growth on a TTM basis, ranked by distance from the 52-week high.
| Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
|---|---|---|---|---|---|
| WKN | Symbol | EPS Growth | Rel. Strength | |||
| 1 | Verisk Analytics | 278.09 $ | 26.37 % | 9.32 % | -3.45 % |
| A0YA2M | VRSK | 88.86 % | 86 | |||
| 2 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
| A2PHB6 | PLMR | 49.48 % | 96 | |||
| 3 | HCI Group | 137.14 $ | 49.16 % | 9.70 % | -1.56 % |
| A1W02H | HCI | 199.39 % | 85 | |||
| 4 | Progressive | 259.68 $ | 22.67 % | 11.37 % | -6.44 % |
| 865496 | PGR | 198.70 % | 88 | |||
| 5 | Universal Technical Institute | 26.47 $ | 20.63 % | 13.39 % | -1.64 % |
| 590097 | UTI | 533.33 % | 96 | |||
| 6 | Halozyme Therapeutics | 56.53 $ | 21.35 % | 14.34 % | -7.15 % |
| A0DLHS | HALO | 60.73 % | 92 | |||
| 7 | Insulet | 246.49 $ | 27.42 % | 14.84 % | -0.76 % |
| A0MQX8 | PODD | 250.00 % | 92 | |||
| 8 | Interdigital | 192.19 $ | 28.53 % | 17.15 % | -9.55 % |
| A0MWY3 | IDCC | 41.33 % | 98 | |||
| 9 | Tradeweb Markets | 122.34 $ | 29.44 % | 19.86 % | -8.22 % |
| TW | 20.69 % | 84 | |||
| 10 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
| A0LCUL | CPRX | 111.86 % | 90 | |||
Subscribe now to see the full ranking
Already a subscriber? Login
Sample Issue
$
0
one issue
Bestseller
Trial Subscription
$
33
1 month